A difficult-to-treat pleuropulmonary histoplasmosis in a patient with rheumatoid arthritis in Taiwan

Amphotericin B and itraconazole are the primary agents for treating histoplasmosis. Newer azoles are alternatives for patients refractory to or intolerant of standard therapy. We report an 83-year-old woman with rheumatoid arthritis complicated with pleuropulmonary histoplasmosis who responded to li...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Wen-Kai Chu, Un-In Wu, Tai-Fen Lee, Aristine Cheng, Kai-Hsiang Chen, Kuan-Yin Lin, Yee-Chun Chen
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2023-02-01
סדרה:	Journal of Microbiology, Immunology and Infection
נושאים:	Histoplasma capsulatum Rheumatoid arthritis Salvage treatment Voriconazole Posaconazole Non-endemic area
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S1684118222002869
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!